The DOI matches its Crossref record; 122 of the 122 references it cites were found in a registry or an index.
Eukaryotic elongation factor-2 kinase (eEF2K) signaling in tumor and microenvironment as a novel molecular target
Abstract
Eukaryotic elongation factor-2 kinase (eEF2K), an atypical member of alpha-kinase family, is highly overexpressed in breast, pancreatic, brain, and lung cancers, and associated with poor survival in patients. eEF2K promotes cell proliferation, survival, and aggressive tumor characteristics, leading to tumor growth and progression. While initial studies indicated that eEF2K acts as a negative regulator of protein synthesis by suppressing peptide elongation phase, later studies demonstrated that it has multiple functions and promotes cell cycle, angiogenesis, migration, and invasion as well as induction of epithelial-mesenchymal transition through induction of integrin β1, SRC/FAK, PI3K/AKT, cyclin D1, VEGF, ZEB1, Snail, and MMP-2. Under stress conditions such as hypoxia and metabolic distress, eEF2K is activated by several signaling pathways and slows down protein synthesis and helping cells to save energy and survive. In vivo therapeutic targeting of eEF2K by genetic methods inhibits tumor growth in various tumor models, validating it as a potential molecular target. Recent studies suggest that eEF2K plays a role in tumor microenvironment cells by monocyte chemoattractant protein-1 (MCP-1) and accumulation of tumor-associated macrophages. Due to its clinical significance and the pivotal role in tumorigenesis and progression, eEF2K is considered as an important therapeutic target in solid tumors. However, currently, there is no specific and potent inhibitor for translation into clinical studies. Here, we aim to systematically review current knowledge regarding eEF2K in tumor biology, microenvironment, and development of eEF2K targeted inhibitors and therapeutics.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“eEF2K signaling intersects with excitation inhibition balance and circuit level plasticity, suggesting strong synergy with circuit specific interventions [159,160,164].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [164]
Citations
Cites
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
MicroRNA expression profiles classify human cancers
Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,539
mTOR Signaling in Growth Control and Disease
Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509
Microenvironmental regulation of tumor progression and metastasis
Quail, D. F., & Joyce, J. A. (2013) · Nature Medicine · doi:10.1038/nm.3394 · Cited by 7,994
MicroRNA signatures in human cancers
Calin, G. A., & Croce, C. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1997 · Cited by 7,590
AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1
Kim, J., Kundu, M., Viollet, B., & Guan, K.-L. (2011) · Nature Cell Biology · doi:10.1038/ncb2152 · Cited by 7,227
Oncomirs—MicroRNAs with a role in cancer
Esquela-Kerscher, A., & Slack, F. J. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1840 · Cited by 5,884
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632
Tumour-associated macrophages as treatment targets in oncology
Mantovani, A., Marchesi, F., Malesci, A., Laghi, L., & Allavena, P. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.217 · Cited by 4,033
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
Biswas, S. K., & Mantovani, A. (2010) · Nature Immunology · doi:10.1038/ni.1937 · Cited by 3,840
Research works printed but not linked: 1
- Tavernarakis N (2013) Protein synthesis. In: Vijg J, Campisi J, Lithgow G (eds) The molecular and cellular biology of aging. Gerontological Society of America (GSA) Press, Washington DC
Cited by
Functionally distinct roles for eEF2K in the control of ribosome availability and p-body abundance
Smith, P. R., Loerch, S., Kunder, N., Stanowick, A. D., Lou, T., & Campbell, Z. T. (2021) · Nature Communications · doi:10.1038/s41467-021-27160-4 · Cited by 58
Ren, Z., Zhang, L., Ding, W., Luo, Y., Shi, Z., Shrestha, B., Kan, X., Zhang, Z., Ding, J., He, H., et al. (2020) · Genomics · doi:10.1016/j.ygeno.2020.11.017 · Cited by 40
Deng, G., Zeng, F., He, Y., Meng, Y., Sun, H., Su, J., Zhao, S., Cheng, Y., Chen, X., & Yin, M. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.722 · Cited by 35
The space between notes: emerging roles for translationally silent ribosomes
Smith, P. R., Pandit, S. C., Loerch, S., & Campbell, Z. T. (2022) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2022.02.003 · Cited by 36
Zhang, B., Zou, J., Zhang, Q., Wang, Z., Wang, N., He, S., Zhao, Y., & Naman, C. B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052408 · Cited by 31
Metadata
- Authors
- Karakas, D., & Ozpolat, B.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Corresponding author
- Ozpolat, Bulent
- ORCID
- Ozpolat, Bulent
- Venue
- Journal of Molecular Medicine
- Published
- 2020-05-07
- Volume
- 98
- Issue
- 6
- Pages
- 775-787
- ISSN
- 0946-2716 (ISSN-L)
- 1432-1440
- OpenAlex
- W3023135453
- Cited by
- 54
- References
- 122
- Citations by year
- 2026: 9 · 2025: 16 · 2024: 8 · 2023: 6 · 2022: 8 · 2021: 5 · 2020: 2
- FWCI
- 0.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Journal of Molecular Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Mechanisms and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- eEF2K, tumor microenvironment, tumor cell proliferation, epithelial-mesenchymal transition, hypoxia, tumor-associated macrophages, MCP-1, PI3K/Akt signaling, targeted cancer therapy, protein synthesis regulation
- MeSH terms
- Animals, Autophagy, Disease Susceptibility, Enzyme Activation, Humans, Neoplasms, Protein Conformation, Structure-Activity Relationship, Biomarkers, Tumor, Signal Transduction, Gene Expression, Gene Expression Regulation, Neoplastic, Apoptosis, RNA, Untranslated, Protein Kinase Inhibitors, Elongation Factor 2 Kinase, Molecular Targeted Therapy, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Eukaryotic elongation factor-2 kinase (eEF2K) signaling in tumor and microenvironment as a novel molecular target. https://app.cochat.ai/papers/10.1007/s00109-020-01917-8
- The paper
- Karakas, D., & Ozpolat, B. (2020). Eukaryotic elongation factor-2 kinase (eEF2K) signaling in tumor and microenvironment as a novel molecular target. Journal of Molecular Medicine. https://doi.org/10.1007/s00109-020-01917-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.